Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips.
There are hundreds of RAC testing centers available worldwide. Any of the four RAC exams (US, EU, CAN or Global) may be taken at any location. Find an upcoming exam at a location near you.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 16 August 2016 | By Zachary Brennan
The European Medicines Agency (EMA) on Tuesday announced that its Committee for Advanced Therapies (CAT) is organizing a workshop on 15 and 16 November 2016 to discuss the scientific and regulatory challenges of immunotherapy medicines based on genetically modified T-cells (white blood cells that fight off viruses and bacteria).
As EMA explains, “Immunotherapy is a type of cancer treatment that mobilizes the body's own defense mechanisms to fight cancer. Immunotherapy medicines have significantly changed the therapeutic landscape, particularly for the treatment of patients with certain cancers, such as lung cancer or melanoma.”
The subject of the workshop is a specific type of immunotherapy that has received a lot of attention and investment this year and focuses on genetically engineering T cells from a patient’s blood in a laboratory in order to allow them to recognize cancer cells through specific receptor proteins, with the hopes of using the modified T-cells to identify and destroy cancer cells.
Despite some early signs of success in some trials, EMA notes that “there are still many scientific and regulatory challenges to be overcome before these innovative products can be brought to the market for the benefit of patients.”
The workshop aims to facilitate dialogue between the CAT and drug developers from industry and academia on:
Stanley Frankel, head of immuno-oncology clinical research and development at Celgene, will present at the workshop on “Taking CARs/TCRs [chimeric antigen receptor (CAR) T-cells] from first-in-man trials to marketing authorisation – the view from a pharmaceutical developer.”
In addition, Maura O’Leary from the US Food and Drug Administration (FDA) will present on FDA’s pilot project to develop a clinical database to examine safety in trials using CAR T cells. FDA previously presented a couple of slides at the DIA conference last June on that database:
The rest of the program for EMA’s workshop can be found here. The event will be broadcast live and those interested in participating are invited to register using the attached form.
Tags: CAR T, CAR T-cell therapies, immuno-oncology, immunotherapy, EMA workshop on immunotherapies
Regulatory Focus newsletters
All the biggest regulatory news and happenings.